Codex DNA Inc.

NASDAQ: DNAY · Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM

Codex DNA Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
30.42M 82.81M
Short-Term Investments
13.16M n/a
Long-Term Investments
n/a n/a
Other Long-Term Assets
981K 609K
Receivables
5.85M 3.67M
Inventory
2.2M 2.37M
Other Current Assets
3.46M 4.34M
Total Current Assets
55.09M 93.18M
Property-Plant & Equipment
8.52M 5.74M
Goodwill & Intangibles
16.77M 16.73M
Total Long-Term Assets
26.27M 23.07M
Total Assets
81.36M 116.26M
Account Payables
1.29M 2.5M
Deferred Revenue
3.96M 205K
Short-Term Debt
637K 1.84M
Other Current Liabilities
7.61M 5.19M
Total Current Liabilities
13.5M 9.73M
Long-Term Debt
20.79M 4.46M
Other Long-Term Liabilities
367K 11.13M
Total Long-Term Liabilities
21.3M 15.74M
Total Liabilities
34.8M 25.47M
Total Debt
21.43M 6.3M
Common Stock
5K 5K
Retained Earnings
-113.74M -65.27M
Comprehensive Income
-3K -116.26M
Shareholders Equity
46.56M 90.78M
Total Investments
13.16M n/a